Torrent Pharmaceuticals Limited (BOM:500420)
India flag India · Delayed Price · Currency is INR
4,482.00
-128.15 (-2.78%)
At close: Oct 23, 2026

Torrent Pharmaceuticals Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
9,13011,1725,7358,3515,0853,984
Short-Term Investments
20,7303,72322.8279581.65.9
Trading Asset Securities
-8,6571,1221,4101,5611,840
Cash & Short-Term Investments
29,86023,5526,88010,0407,2285,830
Cash Growth
276.07%242.34%-31.48%38.91%23.98%-21.01%
Accounts Receivable
33,98030,30918,66518,44319,43816,325
Other Receivables
-6,4853,7733,3902,8442,786
Receivables
34,03036,84622,48021,86322,30019,137
Inventory
31,82031,38225,41322,79122,29624,623
Prepaid Expenses
-981.3631.1589.5666.9514.6
Restricted Cash
-152.649.338.64844.4
Other Current Assets
9,4701,017773.4793753.32,798
Total Current Assets
105,18093,93156,22656,11553,29252,947
Property, Plant & Equipment
54,70053,66038,22935,77834,59832,469
Long-Term Investments
870994.1445.7332.9711.1679.2
Goodwill
39,90039,8963,3893,3803,3752,595
Other Intangible Assets
235,520244,63642,63345,82850,89535,461
Long-Term Deferred Tax Assets
7,1006,9835,9425,5515,4374,937
Other Long-Term Assets
2,8602,9863,0003,5961,7851,894
Total Assets
446,150443,120149,897150,606150,119130,998

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
22,23023,57618,20020,89316,78816,744
Accrued Expenses
-7,0564,1743,7843,6903,111
Short-Term Debt
22,54029,14612,97316,55118,1139,620
Current Portion of Long-Term Debt
-2,3255,8446,95910,3609,718
Current Portion of Leases
460371.9303.7200.6183.3147.3
Current Income Taxes Payable
5,2501,209955.71,679313.1414.8
Current Unearned Revenue
-281.924.45018.3114.8
Other Current Liabilities
29,36019,4684,6984,1345,0074,280
Total Current Liabilities
79,84083,43347,17254,25354,47344,151
Long-Term Debt
116,200116,51211,91816,03824,96221,232
Long-Term Leases
1,8701,9011,459644.6529.3368.2
Long-Term Unearned Revenue
-2244.69.614.619.6
Pension & Post-Retirement Benefits
-936.3813.2836788.1897.5
Long-Term Deferred Tax Liabilities
55,17056,7008,2876,5614,0191,936
Other Long-Term Liabilities
9,3407,5654,3383,7033,3512,865
Total Liabilities
262,420267,27173,99182,04488,13871,469

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
1,9001,6921,6921,6921,692846.2
Additional Paid-In Capital
-----43.4
Retained Earnings
-86,43976,30767,90861,15957,739
Comprehensive Income & Other
181,830-4,247-2,092-1,039-870.5900.6
Total Common Equity
183,73083,88475,90768,56261,98159,530
Minority Interest
-91,964----
Shareholders' Equity
183,730175,84875,90768,56261,98159,530
Total Liabilities & Equity
446,150443,120149,897150,606150,119130,998

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
141,070150,25532,49640,39454,14841,086
Net Cash (Debt)
-111,210-126,703-25,616-30,354-46,921-35,257
Net Cash Growth
------
Net Cash Per Share
-309.49-374.37-75.69-89.69-138.64-104.17
Filing Date Shares Outstanding
380.07338.45338.45338.45338.45338.45
Total Common Shares Outstanding
380.07338.45338.45338.45338.45338.45
Working Capital
25,34010,4989,0541,862-1,1818,796
Book Value Per Share
483.41247.85224.28202.58183.13175.89
Tangible Book Value
-91,690-200,64829,88619,3537,71121,474
Tangible Book Value Per Share
-241.24-592.8588.3057.1822.7863.45
Land
-7,1886,8086,8046,6256,953
Buildings
-21,66415,78514,91011,34311,698
Machinery
-37,61730,95129,16825,81925,792
Construction In Progress
-4,5753,6732,8086,8825,443